These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 424229)

  • 21. [The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
    Lehmann HU; Scholle J; Hochrein H
    MMW Munch Med Wochenschr; 1974 Nov; 116(46):2019-26. PubMed ID: 4141058
    [No Abstract]   [Full Text] [Related]  

  • 22. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
    Lehmann H; Hochrein H
    Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ambulatory treatment experience with lidoflazine in ischemic heart disease].
    Pmerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1980 Jul; 20(7):109-10. PubMed ID: 7401433
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of lidoflazin in the treatment of ischemic heart disease].
    Fomina AA; Mironova KA; Glomozda NIa; Klimovich MD
    Vrach Delo; 1977 Mar; (3):68-71. PubMed ID: 855300
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of intravenous lidoflazine on whole blood-induced basilar artery contraction. An in vivo study.
    Rosenwasser RH; Tuma RF; Buchheit WA; McDowell A
    Surg Neurol; 1987 Jun; 27(6):533-6. PubMed ID: 3576428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of treatment of a coronary pain syndrome with lidoflazine].
    Dvorák I; Zemánková J; Soják K
    Vnitr Lek; 1973 Oct; 19(10):943-8. PubMed ID: 4586010
    [No Abstract]   [Full Text] [Related]  

  • 28. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation and hyperthyroidism: a new look at their relationship and therapy with lidoflazine.
    Bruyneel K; Verhaegen H; De Vil C
    Postgrad Med J; 1975 Jan; 51(591):4-9. PubMed ID: 1161678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ultrastructure of human livers after prolonged lidoflazine therapy.
    Verheyen A; Borgers M; Blaton H; Sowa H
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):224-32. PubMed ID: 1209621
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting.
    Flameng W; Borgers M; Van der Vusse GJ; Demeyere R; Vandermeersch E; Thoné F; Suy R
    J Thorac Cardiovasc Surg; 1983 May; 85(5):758-68. PubMed ID: 6601746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)].
    Lehmann HU; Hochrein H
    Z Kardiol; 1975 Aug; 64(8):741-8. PubMed ID: 1099831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
    Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
    Teichmann W; Vogel HC; Schäbitz J; Schmeisser M; Lukesch KH
    Z Gesamte Inn Med; 1976 Mar; 31(6):161-6. PubMed ID: 941465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exercise tolerance and working capacity of the left ventricle after pharmacologic disruption of atrial fibrillation and restoration of sinus rhythm].
    Zikmund M; Hůla J
    Vnitr Lek; 1981 Oct; 27(10):970-5. PubMed ID: 7314537
    [No Abstract]   [Full Text] [Related]  

  • 36. [Controlled study oflidoflazine in ischemic heart disease].
    Demin AA; Balashov VA
    Kardiologiia; 1977 Dec; 17(12):125. PubMed ID: 340757
    [No Abstract]   [Full Text] [Related]  

  • 37. [Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
    Schaper W
    Brux Med; 1973 Sep; 53(9):523-7. PubMed ID: 4202038
    [No Abstract]   [Full Text] [Related]  

  • 38. [Severe hypertrophic myocardiopathy in newborn infants. Intra-erythrocyte calcium and the effect of lidoflazine, a calcium-channel inhibitor. Apropos of 2 cases].
    Vliers A; Stijns-Cailteux M; Lintermans J; Trémouroux-Wattiez M; Godfraind T
    Arch Mal Coeur Vaiss; 1984 May; 77(5):496-502. PubMed ID: 6428345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent, atypical ventricular tachycardia "torsade des pointes" following administration of lidoflazine].
    Kaden F; Kübler W
    Med Welt; 1978 Jun; 29(25):1047-8. PubMed ID: 661553
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recurrent atypical ventricular tachycardia "torsade de pointes" following lidoflazine administration].
    Kaden F; Kübler W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1596-7. PubMed ID: 611885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.